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Abstract
Background: Epidemiology and surveillance of neonatal sepsis helps in implementation of rational empirical
antibiotic strategy.
Objective: To study the frequency of bacterial isolates of early onset neonatal sepsis (EONS) and their sensitivity
pattern.
Methods: In this retrospective study, a case of EONS was defined as an infant who had clinical signs or born to
mothers with potential risk factors for infection, in whom blood culture obtained within 72 hours of life, grew a
bacterial pathogen. Blood culture sample included a single sample from peripheral vein or artery. Relevant data
was obtained from the unit register or neonatal case records.
Results: Of 2182 neonates screened, there were 389 (17.8%) positive blood cultures. After excluding coagulase-
negative Staphylococci (160), we identified 229 EONS cases. Preterm neonates were 40.6% and small for gestational
age, 18.3%. Mean birth weight and male to female ratio were 2344.5 (696.9) g and 1.16:1 respectively. Gram negative
species represented 90.8% of culture isolates. Pseudomonas (33.2%) and Klebsiella (31.4%) were common among
them. Other pathogens included Acinetobacter (14.4%), Staphylococcus aureus (9.2%), E.coli (4.4%), Enterobacter
(2.2%), Citrobacter (3.1%) and Enterococci (2.2%). In Gram negative group, best susceptibility was to Amikacin (74.5%),
followed by other aminoglycosides, ciprofloxacin and cefotaxime. The susceptibility was remarkably low to ampicillin
(8.4%). Gram positive group had susceptibility of 42.9% to erythromycin, 47.6% to ciprofloxacin and above 50% to
aminoglycosides. Of all isolates, 83.8% were susceptible to either cefotaxime or amikacin
Conclusion: Gram-negative species especially Pseudomonas and Klebsiella were the predominant causative
organisms. Initial empirical choice of cefotaxime in combination with amikacin appeared to be rational choice for a
given cohort.
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Background
Early onset bacterial infection places the neonate at risk of
death and long term morbidity [1-,3]. Improvement in
outcome and successful treatment depends on early initia-
tion of appropriate antibiotic therapy. The pattern of cau-
sative organisms has been constantly changing [4] and the
frequent emergence of resistant bacteria [5] compounds
the problem further. This highlights the need for
surveillance of sepsis for optimum therapy. Knowledge of
likely causative organisms and their antimicrobial sensitiv-
ity pattern could aid in choosing prompt and appropriate
therapy for early-onset neonatal sepsis (EONS). The epide-
miology of EONS in the developed and developing coun-
tries shows some important differences in the pattern of
etiological bacteria and their antibiotic susceptibility
[1-3,6,7]. In developed countries, Group B Streptococcus
(GBS) was the common etiological agent for EONS [6,7].
Following adoption of preventive strategies for GBS,
Escherichia coli (E.coli) was identified as predominant
pathogen [7,8]. Developing nations reported an entirely a
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different bacterial spectrum [3,7,9-11]. Current study was
undertaken to find out the common bacterial pathogens
and their susceptibility pattern in neonates with early
onset sepsis in a tertiary care hospital providing neonatal
intensive care services.
Methods
Present study was carried out in a neonatal unit of Kas-
turba Hospital, Kasturba Medical College, Manipal from
January 1998 to December 2004. We retrospectively evalu-
ated the case records of neonates who had EONS. A case
of EONS was defined as an infant who had clinical signs of
sepsis or those who were born to mothers with potential
risk factors for infection, in whom blood culture obtained
within 72 hours of life, grew a bacterial pathogen. Risk fac-
tors in the mother included prolonged rupture of mem-
branes (PROM) of >12hours, fever, urinary tract infection,
chorioamnionitis and meconium stained amniotic fluid.
Blood culture sample included a single sample collected
from a peripheral vein or artery under aseptic conditions.
The local site was cleansed with 70% alcohol and povidone
iodine (1%) followed by 70% alcohol again. Blood cultures
were done in Brain Heart Infusion biphasic medium. Sub-
cultures were done on Sheep blood agar and MacConkey
agar at the earliest visual detection of turbidity or blindly
on days 1, 4 and 7 if the bottles did not show turbidity.
Gram’s staining was performed on the bottles showing tur-
bidity. Bacterial isolates were identified and antimicrobial
susceptibility test was performed using Kirbey Bauer disc
diffusion method. (Reference -National Committee for
Clinical Laboratory Standards. Performance standards for
antimicrobial disk susceptibility tests; Approved standard.
7th ed. NCCLS Document M2 - A7. Wayne, PA: National
Committee for Clinical Laboratory Standards, 2000.) After
obtaining blood for culture, the neonates were adminis-
tered intravenous ampicillin and gentamicin as the first
line of antibiotics. Antibiotic therapy was continued or
changed, based on the isolation of organisms in the blood
culture and their sensitivity pattern. Other neonatal inten-
sive care and support were given as required. CSF analysis
was done when there was clinical suspicion of meningitis
and in whom blood culture grew microorganism. Urine
and other cultures were obtained on indications. The
demographic data, blood culture reports, organisms and
their antibiotic susceptibility were obtained from the unit
register and/or neonatal case records. Neonates with blood
cultures that grew only coagulase-negative staphylococcus
were excluded. Data was analyzed using Statistical Package
for Social Sciences (SPSS) version 11.5 software.
Results
Of 2182 neonates screened for EONS, there were 389
(17.8%) positive blood cultures. After excluding growth
of coagulase-negative Staphylococci (160 cases, 41.1%),
we identified 229 cases of EONS. Both blood and CSF
cultures were positive in 8(3.5%) cases. Demographic
characteristics of 229 neonates were shown in Table 1.
The male to female ratio was 1.16:1. The predisposing
factors and comorbid conditions were shown in table 2.
Obstetric risk factors and preterm delivery was present
in 54.6% (125/229). Figure 1 shows the distribution of
bacterial isolates from blood cultures. During the 7
years period, 208 (90.8%) sepsis cases were attributable
to Gram negative species and 21 (9.2%) were attributa-
ble to Gram positive species. Pseudomonas spp (33.2%
of all isolates, 36.5% of Gram-negatives) and Klebsiella
pneumoniae (31.4% of all isolates, 34.6% of Gram-nega-
tive isolates) were the common isolates that accounted
for nearly 2/3rd of total blood culture isolates. Acineto-
bacter spp (14.4%) was the third common organism.
Staphylococcus aureus represented 9.2%( 21/229). Other
pathogens included E.coli (10), Enterobacter spp (5),
Citrobacter spp (7) and Enterococcus spp (5).
Table 3 shows the antibiotic susceptibility pattern of dif-
ferent bacterial isolates. Pseudomonas species were mostly
susceptible to amikacin, moderately to gentamicin, netil-
micin and ciprofloxacin, and less susceptible to ceftazi-
dime and piperacillin. Klebsiella and Acinetobacter species
were more susceptible to amikacin and moderately to
other aminoglycosides, third generation cephalosporins
and ciprofloxacin. E.coli and other gram negative bacilli
were susceptible to amikacin and netilmicin but remark-
ably less sensitive to ampicillin. S.aureus was better sus-
ceptible to erythromycin, ciprofloxacin, vancomycin and
amikacin when compared to ampicillin and cefotaxime.
All Enterococci were susceptible to vancomycin. There
were three methicillin resistant Staphylococci and they
were susceptible to vancomycin.
In Gram negative group, best overall sensitivity was to
amikacin (74.5%). Gram positive group had sensitivity of
42.9% to erythromycin, 47.6% to ciprofloxacin and
above 50% to aminoglycosides (Table 3 and Table 4)
Discussion
We conducted an audit of positive blood cultures
obtained from neonates with EONS over 7 years. The
blood culture yield was about 18%. This is low com-
pared to about 20% yield reported by Baltimore et al [8]
Table 1 Demographic characteristics (n = 229)





Small for gestational age 42 (18.3%)
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and Gladstone et al [12]. Earlier, culture positive rate of
26% by Ahmed et al [11] and much higher rates of 51%
by Karthikeyan [13] and 64% by Tallur et al [14] were
reported. We used conventional blood culture techni-
ques in the present study. The automated systems like
BacT alert may provide the results earlier and improve
the yield [15]. Coagulase-negative Staphylococcus
(CONS) has been identified as causative organism for
EONS. In a study by Agarwal et al [16], approximately
two third of CONS sepsis has developed within first
three days of life. We excluded CONS from analysis
because we used single blood sample for culture and it
was difficult to analyse the response to antibiotics from
the retrospective nature of the study, although discrimi-
nating true CONS infection from contamination, from
single culture has been recognized [17]. Mothers
received amoxicillin injections whenever indicated to
reduce neonatal sepsis.
A male predominance was found in our study which
agrees with previous reports [2,11,18-20]. Among the
neonates in whom blood culture was positive, prematur-
ity and obstetric factors were present in 54.6% (125/229).
Schuchat et al [21] found an obstetric risk factor-preterm
delivery, intrapartum fever, or membrane rupture >/ = 18
hours in 49% of GBS and 79% of other sepsis. In an
attempt to identify possible risk factors for EONS, Biz-
zarro et al [19] found preterm labor in 43%, fever before
delivery in 26%, prolonged rupture of membranes in 46%
and chorioamnionitis in 20%. A significant association of
EONS with prolonged rupture of membranes and foul
smelling liquor was found by Chacko and Sohi [3]. They
Table 2 Predisposing factors and comorbidity among
blood culture positive neonates (n = 229)
Number %





Prematurity alone 47 20.5
Perinatal asphyxia 10 4.4
RDS 14 6.1




Congenital malformations 13 5.7
PROM, prolonged rupture of membranes; MSAF, meconium stained amniotic
















Figure 1 Bacterial isolates of early onset sepsis (n = 229)
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also found among infants at risk of EOS, 20.6% developed
sepsis compared to only 0.5% of those without these risk
factors. Tallur et al [14] reported association of PROM >
24 hours in 14% and perinatal asphyxia in 22%. Associa-
tion of meconium stained amniotic fluid with sepsis was
identified by Kuruvilla et al [9]. Agarwal et al [16] found
EONS more frequently in neonates with perinatal
asphyxia.
Bacteria causing neonatal sepsis continue to change
[4-10,19,22,23]. They also differ from developed to devel-
oping country and place to place. In industrialized world
GBS caused EONS predominantly [2,6,7,21,22,24,25]. E.
coli was 2nd most common. Following GBS prophylaxis,
decreasing incidence of GBS [5,7,8,26] and increased rate
of E.coli infections [5,7,8] have been reported. Significant
proportions (50%-37%) of EONS due to gram positive
organisms were reported from recent studies [6-8]. In
contrast, 90.2% of isolates were gram negative species in
the present study. Predominance of gram negative iso-
lates (67.2%-92.5%) has been reported by developing
countries [7,8,11,18,27].
Following GBS prophylaxis, industrialized countries
identified E.coli as the predominant organism for EONS.
Developing countries also identified E.coli as the most
common causative organism [9,10]. Rate of E.coli infection
varied from 15.7%- 77.1%. Other studies from developing
world found Klebsiella as the common organism [4,14].
Rate of Klebsiella infection varies from 8.9%-64%. In con-
trast, we identified Pseudomonas species as the predomi-
nant isolates. Similar observations were reported by Joshi
et al [18] and Tallur et al [14,3]. Pseudomonas isolation
rate varies from 8.9%-38.3%.
Acinetobacter accounted for 14.4% of EONS in our
study. Infection rate up to 7.8% has been recognized
[9,11,18]. Infection rates of other gram-negative organisms
in the present study were similar to earlier reports [3,9,14].
The rate of S. aureus infection in the present study was
9.2%. Similar reports with rate of infection varying from
3.7%- 7% have been found previously [5,10,14]. However,
Karthikeyan and Premkumar [13], in their analysis identi-
fied S aureus as a predominant pathogen (50% of EONS).
A low rate of entrococci infection of present study is simi-
lar to the observations of Dobson and Baker [28].
Antibiotic susceptibility
In the present study, Pseudomonas species were best sus-
ceptible to amikacin, moderately to gentamicin, netilmi-
cin and ciprofloxacin, and less susceptible to ceftazidime
and piperacillin. Above 60% sensitivity of the organism to
aminoglycoside is recognized [14]. Lower susceptibility to
amikacin (45%) was found by Agarwal et al [16]. In con-
trast, Pseudomonas aeruginosa in a study with controlled
Table 3 Antibiotic susceptibility pattern of blood culture isolates (% susceptible)
Pseudomonas Klebsiella Acineto-bacter S.aureus E.coli Entero-bacter Citro-bacter Entero-cocci
Ampicillin NT 6.9 33.3 28.6 20 0 12.5 20
Gentamicin 56.6 25 48.5 61.9 40 0 25 20
Amikacin 76.3 77.8 66.7 76.2 70 100 50 NT
Netilmycin 56.6 31.9 66.7 52.4 30 40 75 NT
Tobramycin 26.3 6.9 33.3 NT 20 40 25 NT
TMP/SMX NT 33.3 21.2 28.5 40 20 25 0
Ciprofloxacin 40.8 51.4 36.4 47.6 20 80 50 40
Piperacillin 23.7 NT NT NT NT NT NT NT
Vancomycin NT NT NT 100 NT NT NT 100
Cefuroxime NT 5.6 6.1 14.2 7 8 12.5 NT
Cefotaxime NT 43 27.3 28.5 40 20 37.5 NT
Ceftazidime 14.5 45.8 36.3 NT 10 0 12.5 NT
Erythromycin NT NT NT 42.9 NT NT NT NT
’NT’ means not tested.
















NT = not tested
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antibiotic programs by Cordero et al [6] remained fully
susceptible to ceftazidime and gentamicin. Klebsiella
and Acinetobacter species of present study were more
susceptible to amikacin and moderately to other amino-
glycosides, third generation cephalosporins and cipro-
floxacin. Higher sensitivity to aminoglycosides was
reported by Agarwal et al [16] and Kuruvilla et al [9].
Low sensitivity to ampicillin is similar in all these studies.
E.coli and other gram negative bacilli were susceptible
to amikacin and netilmicin but remarkably less sensitive
to ampicillin. High sensitivity (up to 93.7%) of E.coli to
amikacin [14,16] and uniform susceptibility to cephalos-
porins have been described [14,19]. Low sensitivity of
E.coli to ampicillin in the present study is similar to
many earlier studies [5,14,19,21].
S.aureus of present study was better susceptible to ery-
thromycin, ciprofloxacin, vancomycin and amikacin when
compared to ampicillin and cefotaxime. Staphylococcal
resistance of 79.3% to ampicillin [10] and low sensitivity to
all commonly used antibiotics [13] were described in the
literature. Susceptibility of Enterococci in the present
study to aminoglycoside is similar to the observations of
Dobson and Baker [28].
Sensitivity of bacterial groups (Gram negative and Gram
positive)
In the current study all isolates were best sensitive to
amikacin while relatively less sensitive to other aminogly-
cosides. Good sensitivity of organisms to amikacin has
been found by other researchers [10,14,16]. Some studies
found good sensitivity to gentamicin [11,29,30]. The sen-
sitivity was 17.5% to ampicillin. Cefotaxime had better
sensitivity but only 32.3%. Low sensitivity of bacteria
causing EONS to commonly used antibiotics has been
found by other authors [10,14,19]. Tallur et al [14]
reported that most isolates were resistant to ampicillin,
gentamicin and cotrimaxazole. Ampicillin resistance of
all Klebsiella isolates was reported by Thaver et al [31].
In contrast, good response to ampicillin has been found
by Cordero et al [6] and to ampicillin-sulbactum by
Mokuolu [27]. No increase in ampicillin resistant organ-
isms following intrapartum antibiotics prophylaxis has
also been reported [32]. Gram negative group had best
overall sensitivity to Amikacin (74.5%), followed by other
aminoglycosides and ciprofloxacin. Cephalosporins had
low sensitivity. Higher sensitivity of gram negative group
to gentamicin and ceftazidime has been reported by
Mokuolu [27] and good sensitivity to cephalosporins by
others [11,14]. Meropenem sensitivity was tested since
2003. Gram negative organisms were universally suscep-
tible to meropenem.
Of all isolates, 83.8% (192/229) were sensitive to either
cefotaxime or amikacin and hence using this combina-
tion as the initial choice while awaiting blood culture
reports seems reasonable. However, these results are
limited to study cohorts and every center should have
its own control on their bacterial strains.
Conclusion
Bacterial spectrum for EONS could be different in
developed and developing countries. Continued surveil-
lance of neonatal sepsis is mandatory for each center
due to temporal changes in the causative organisms and
their antibiotic susceptibility. Periodic evaluations not
only show the trend of increasing resistance to com-
monly used antibiotics but also help in implementation
of a rational empirical treatment strategy. Present study
indicated that Gram-negative species continue to be the
predominant causative organisms among study cohorts.
Pseudomonas and Klebsiella played a major role and,
Acinetobacter, Staphylococci and E.coli contributed to
the rest. A low susceptibility to commonly used antibio-
tics like ampicillin is a cause for concern. The antibiotic
susceptibility profiles suggested that for a given cohort,
initial empirical choice of cefotaxime in combination
with amikacin was the most rational.
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